TD Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $971K | Buy |
+45,000
| New | +$971K | ﹤0.01% | 1065 |
|
2024
Q3 | – | Sell |
-23,296
| Closed | -$379K | – | 1386 |
|
2024
Q2 | $379K | Sell |
23,296
-82,800
| -78% | -$1.35M | ﹤0.01% | 1305 |
|
2024
Q1 | $1.96M | Sell |
106,096
-100,400
| -49% | -$1.86M | ﹤0.01% | 1029 |
|
2023
Q4 | $6.47M | Sell |
206,496
-19,200
| -9% | -$601K | 0.01% | 697 |
|
2023
Q3 | $4.7M | Buy |
225,696
+51,273
| +29% | +$1.07M | 0.01% | 745 |
|
2023
Q2 | $4.18M | Buy |
174,423
+57,502
| +49% | +$1.38M | ﹤0.01% | 786 |
|
2023
Q1 | $2.2M | Buy |
116,921
+13,600
| +13% | +$256K | ﹤0.01% | 954 |
|
2022
Q4 | $1.64M | Sell |
103,321
-23,339
| -18% | -$372K | ﹤0.01% | 1042 |
|
2022
Q3 | $2.04M | Buy |
126,660
+15,300
| +14% | +$247K | ﹤0.01% | 991 |
|
2022
Q2 | $1.57M | Buy |
111,360
+15,400
| +16% | +$217K | ﹤0.01% | 1075 |
|
2022
Q1 | $2.32M | Sell |
95,960
-40,882
| -30% | -$990K | ﹤0.01% | 1043 |
|
2021
Q4 | $3.19M | Buy |
136,842
+11,791
| +9% | +$275K | ﹤0.01% | 1006 |
|
2021
Q3 | $2.08M | Sell |
125,051
-12,700
| -9% | -$211K | ﹤0.01% | 1073 |
|
2021
Q2 | $2.98M | Sell |
137,751
-1,766
| -1% | -$38.2K | ﹤0.01% | 964 |
|
2021
Q1 | $3.6M | Sell |
139,517
-43,656
| -24% | -$1.13M | ﹤0.01% | 924 |
|
2020
Q4 | $9.79M | Sell |
183,173
-59,200
| -24% | -$3.16M | 0.01% | 597 |
|
2020
Q3 | $10M | Sell |
242,373
-13,100
| -5% | -$540K | 0.01% | 547 |
|
2020
Q2 | $12.4M | Buy |
255,473
+10,297
| +4% | +$499K | 0.02% | 468 |
|
2020
Q1 | $10.4M | Sell |
245,176
-37,943
| -13% | -$1.6M | 0.02% | 463 |
|
2019
Q4 | $12.1M | Buy |
283,119
+75,214
| +36% | +$3.22M | 0.02% | 502 |
|
2019
Q3 | $7.48M | Buy |
207,905
+42,456
| +26% | +$1.53M | 0.01% | 592 |
|
2019
Q2 | $4.42M | Buy |
165,449
+5,700
| +4% | +$152K | 0.01% | 711 |
|
2019
Q1 | $4.29M | Buy |
159,749
+12,500
| +8% | +$336K | 0.01% | 732 |
|
2018
Q4 | $2.38M | Buy |
147,249
+39,649
| +37% | +$641K | ﹤0.01% | 871 |
|
2018
Q3 | $2.23M | Buy |
+107,600
| New | +$2.23M | ﹤0.01% | 964 |
|
2017
Q4 | – | Sell |
-32,761
| Closed | -$1.23M | – | 1330 |
|
2017
Q3 | $1.23M | Sell |
32,761
-29,500
| -47% | -$1.11M | ﹤0.01% | 984 |
|
2017
Q2 | $1.74M | Sell |
62,261
-23,400
| -27% | -$652K | ﹤0.01% | 909 |
|
2017
Q1 | $2.95M | Sell |
85,661
-28,726
| -25% | -$988K | ﹤0.01% | 810 |
|
2016
Q4 | $3.3M | Sell |
114,387
-27,300
| -19% | -$787K | 0.01% | 763 |
|
2016
Q3 | $4.51M | Sell |
141,687
-9,313
| -6% | -$296K | 0.01% | 725 |
|
2016
Q2 | $4.9M | Sell |
151,000
-26,400
| -15% | -$857K | 0.01% | 681 |
|
2016
Q1 | $4.96M | Buy |
177,400
+46,900
| +36% | +$1.31M | 0.01% | 677 |
|
2015
Q4 | $4.65M | Sell |
130,500
-4,400
| -3% | -$157K | 0.01% | 679 |
|
2015
Q3 | $4.46M | Buy |
134,900
+6,000
| +5% | +$198K | 0.01% | 661 |
|
2015
Q2 | $5.4M | Sell |
128,900
-2,900
| -2% | -$121K | 0.01% | 645 |
|
2015
Q1 | $4.3M | Buy |
131,800
+13,700
| +12% | +$446K | 0.01% | 699 |
|
2014
Q4 | $3.75M | Buy |
118,100
+3,000
| +3% | +$95.3K | 0.01% | 735 |
|
2014
Q3 | $2.85M | Buy |
115,100
+8,000
| +7% | +$198K | ﹤0.01% | 767 |
|
2014
Q2 | $2.42M | Buy |
107,100
+65,900
| +160% | +$1.49M | ﹤0.01% | 803 |
|
2014
Q1 | $1M | Buy |
41,200
+3,300
| +9% | +$80.3K | ﹤0.01% | 905 |
|
2013
Q4 | $947K | Buy |
37,900
+5,200
| +16% | +$130K | ﹤0.01% | 890 |
|
2013
Q3 | $898K | Buy |
32,700
+3,800
| +13% | +$104K | ﹤0.01% | 885 |
|
2013
Q2 | $525K | Buy |
+28,900
| New | +$525K | ﹤0.01% | 925 |
|